• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液存储条件对自动平台阿尔茨海默病诊断的重要性。

Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform.

机构信息

Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB) Sant Pau, Barcelona, Spain.

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB) Sant Pau, Barcelona, Spain.

出版信息

Clin Chem Lab Med. 2022 Apr 12;60(7):1058-1063. doi: 10.1515/cclm-2022-0134. Print 2022 Jun 27.

DOI:10.1515/cclm-2022-0134
PMID:35405043
Abstract

OBJECTIVES

Alzheimer's disease (AD) is considered the most common cause of dementia in older people. Cerebrospinal fluid (CSF) Aβ1-42, Aβ1-40, total Tau (t-Tau), and phospho Tau (p-Tau) are important biomarkers for the diagnosis, however, they are highly dependent on the pre-analytical conditions. Our aim was to investigate the potential influence of different storage conditions on the simultaneous quantification of these biomarkers in a fully-automated platform to accommodate easier pre-analytical conditions for laboratories.

METHODS

CSF samples were obtained from 11 consecutive patients. Aβ1-42, Aβ1-40, p-Tau, and t-Tau were quantified using the LUMIPULSE G600II automated platform.

RESULTS

Temperature and storage days significantly influenced Aβ1-42 and Aβ1-40 with concentrations decreasing with days spent at 4 °C. The use of the Aβ1-42/Aβ1-40 ratio could partly compensate it. P-Tau and t-Tau were not affected by any of the tested storage conditions. For conditions involving storage at 4 °C, a correction factor of 1.081 can be applied. Diagnostic agreement was almost perfect in all conditions.

CONCLUSIONS

Cutoffs calculated in samples stored at -80 °C can be safely used in samples stored at -20 °C for 15-16 days or up to two days at RT and subsequent freezing at -80 °C. For samples stored at 4 °C, cutoffs would require applying a correction factor, allowing to work with the certainty of reaching the same clinical diagnosis.

摘要

目的

阿尔茨海默病(AD)被认为是老年人痴呆症的最常见原因。脑脊液(CSF)中的 Aβ1-42、Aβ1-40、总 Tau(t-Tau)和磷酸化 Tau(p-Tau)是诊断的重要生物标志物,然而,它们高度依赖于分析前条件。我们的目的是研究不同储存条件对这些生物标志物在全自动平台上同时定量的潜在影响,以适应实验室更简单的分析前条件。

方法

从 11 名连续患者中获得 CSF 样本。使用 LUMIPULSE G600II 自动化平台定量测定 Aβ1-42、Aβ1-40、p-Tau 和 t-Tau。

结果

温度和储存天数对 Aβ1-42 和 Aβ1-40 有显著影响,浓度随 4°C 储存天数的增加而降低。使用 Aβ1-42/Aβ1-40 比值可以部分补偿。任何测试的储存条件都不会影响 p-Tau 和 t-Tau。对于涉及 4°C 储存的条件,可以应用 1.081 的校正因子。在所有条件下,诊断一致性几乎都是完美的。

结论

在-80°C 储存的样本中计算的截止值可安全地用于在-20°C 储存 15-16 天或在 RT 下储存最多两天,随后在-80°C 下冷冻的样本中使用。对于在 4°C 下储存的样本,截止值需要应用校正因子,以确保达到相同的临床诊断。

相似文献

1
Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform.脑脊液存储条件对自动平台阿尔茨海默病诊断的重要性。
Clin Chem Lab Med. 2022 Apr 12;60(7):1058-1063. doi: 10.1515/cclm-2022-0134. Print 2022 Jun 27.
2
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform.脑脊液储存量对自动化平台上阿尔茨海默病生物标志物分析的影响。
Clin Chim Acta. 2019 Mar;490:98-101. doi: 10.1016/j.cca.2018.12.021. Epub 2018 Dec 20.
3
Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ and T-Tau assays for Alzheimer's disease diagnosis.用于阿尔茨海默病诊断的自动 Lumipulse 脑脊液 Aβ 和 T-Tau 分析及临床性能。
J Neurol. 2019 Sep;266(9):2304-2311. doi: 10.1007/s00415-019-09418-6. Epub 2019 Jun 10.
4
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.建立阿尔茨海默病中心巴塞罗那队列 AT(N)分层的脑脊液阿尔茨海默病生物标志物内部截断值。
Int J Mol Sci. 2022 Jun 21;23(13):6891. doi: 10.3390/ijms23136891.
5
CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.脑脊液生物标志物与淀粉样 PET 检测在 MCI 队列中的一致性和诊断准确性。
Acta Neurol Belg. 2019 Sep;119(3):445-452. doi: 10.1007/s13760-019-01112-8. Epub 2019 Mar 7.
6
Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.[11C]PIB正电子发射断层扫描(PET)与脑脊液生物标志物在轻度认知障碍和阿尔茨海默病患者样本中的一致性及诊断准确性
J Alzheimers Dis. 2015;45(4):1077-88. doi: 10.3233/JAD-142952.
7
Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.社交网络与认知正常老年人阿尔茨海默病病理的脑脊液生物标志物:CABLE 研究。
J Alzheimers Dis. 2021;81(1):263-272. doi: 10.3233/JAD-201426.
8
Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging.两种分析平台在脑脊液生物标志物用于阿尔茨海默病谱系与淀粉样蛋白PET成像分类中的比较
J Alzheimers Dis. 2020;75(3):949-958. doi: 10.3233/JAD-191331.
9
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.用于识别阿尔茨海默病淀粉样斑块病理的脑脊液β-淀粉样蛋白1-42、总tau蛋白和磷酸化tau181检测分析平台的比较。
Arch Neurol. 2011 Sep;68(9):1137-44. doi: 10.1001/archneurol.2011.105. Epub 2011 May 9.
10
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.在 Lumipulse 上淀粉样蛋白 PET 和 CSF 生物标志物对阿尔茨海默病的一致性。
Ann Clin Transl Neurol. 2019 Sep;6(9):1815-1824. doi: 10.1002/acn3.50873. Epub 2019 Aug 28.

引用本文的文献

1
Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease.储存条件对阿尔茨海默病诊断用基于血液标志物稳定性的影响。
Clin Chem Lab Med. 2023 Apr 24;61(9):1580-1589. doi: 10.1515/cclm-2023-0245. Print 2023 Aug 28.
2
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's Disease.一种检测脑脊液β淀粉样蛋白1-42和1-40、总tau蛋白和磷酸化tau蛋白的新型自动化化学发光方法:对提高阿尔茨海默病诊断性能的意义。
Biomedicines. 2022 Oct 21;10(10):2667. doi: 10.3390/biomedicines10102667.